Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|April 5, 2011

Camargo Expands, Opens New Office in The Research Triangle Park

Camargo Pharmaceutical Services, an end-to-end drug development company specializing in the 505(b)(2) process, has announced today its expansion into The Research Triangle Park (RTP) with the opening of a new office. The new location will pave the way for additional opportunities and service offerings, as well as streamlining client service.

Camargo’s decision to expand its reach to the east coast, specifically RTP, abides with the Company’s overall growth goals and global service coverage. RTP, the largest research park in the nation, is a 7,000-acre development that is home to more than 170 companies.

Camargo is focused on global drug development through the 505(b)(2) process and provides a full spectrum of services from discovery through each phase of clinical development.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.